Skip to main content
Top
Published in: Dermatology and Therapy 2/2023

Open Access 21-12-2022 | Review

Supersaturation as a Galenic Concept for Improving the Cutaneous Bioavailability of Drugs in Topical Therapy

Authors: Johannes Wohlrab, Adina Eichner

Published in: Dermatology and Therapy | Issue 2/2023

Login to get access

Abstract

The essential force that allows an epicutaneously applied drug to penetrate the skin is mediated by diffusion. The physicochemical properties of the skin tissue at the site of application and the concentration gradient of the dissolved drug between the vehicle and the stratum corneum are decisive here. One way to specifically improve these diffusion conditions is to use supersaturation. This uses the physical principle of the difference between the solubility curve and precipitation curve (Ostwald-Miers range). During the conversion of the application vehicle into the segregation vehicle, supersaturation of the dissolved drug substance in a solvent is achieved by evaporation, e.g., of a solubilizer. In principle, the change in solubility can also be achieved by heating and then cooling a solution. This principle has already been realized in a formulation of a fixed combination of calcipotriol and betamethasone dipropionate, two lipophilic drugs susceptible to hydrolysis, and is available on the market as a spray foam.
Literature
1.
go back to reference Ludwig W-D, Mühlbauer B, Seifert RE. Arzneimittelverordnungs-Report 2021. Springer Verlag; 2022. Ludwig W-D, Mühlbauer B, Seifert RE. Arzneimittelverordnungs-Report 2021. Springer Verlag; 2022.
2.
go back to reference Wohlrab J, Staubach P, Augustin M, Eisert L, Hunerbein A, Nast A, Reimann H, Stromer K, Mahler V. S2k-Leitlinie zum Gebrauch von Praparationen zur lokalen Anwendung auf der Haut (Topika). J Dtsch Dermatol Ges. 2018;16:376–92. Wohlrab J, Staubach P, Augustin M, Eisert L, Hunerbein A, Nast A, Reimann H, Stromer K, Mahler V. S2k-Leitlinie zum Gebrauch von Praparationen zur lokalen Anwendung auf der Haut (Topika). J Dtsch Dermatol Ges. 2018;16:376–92.
3.
4.
go back to reference Wohlrab J, Klauck D, Savtcheva E. Regulatorische besonderheiten von topika. Hautarzt. 2014;65:175–9.CrossRef Wohlrab J, Klauck D, Savtcheva E. Regulatorische besonderheiten von topika. Hautarzt. 2014;65:175–9.CrossRef
5.
go back to reference Wohlrab J. Influence of keratolytics on cutaneous pharmacokinetics of glucocorticoids. J Dtsch Dermatol Ges. 2021;19:554–61. Wohlrab J. Influence of keratolytics on cutaneous pharmacokinetics of glucocorticoids. J Dtsch Dermatol Ges. 2021;19:554–61.
6.
go back to reference Wohlrab J. Topicals and their use in dermatology. J Dtsch Dermatol Ges. 2016;14:1061–71. Wohlrab J. Topicals and their use in dermatology. J Dtsch Dermatol Ges. 2016;14:1061–71.
7.
go back to reference Surber C, Knie U. Metamorphosis of vehicles: mechanisms and opportunities. Curr Probl Dermatol. 2018;54:152–65.CrossRef Surber C, Knie U. Metamorphosis of vehicles: mechanisms and opportunities. Curr Probl Dermatol. 2018;54:152–65.CrossRef
8.
go back to reference Scheuplein RJ. Mechanism of percutaneous absorption. II. Transient diffusion and the relative importance of various routes of skin penetration. J Invest Dermatol. 1967;48:79–88.CrossRef Scheuplein RJ. Mechanism of percutaneous absorption. II. Transient diffusion and the relative importance of various routes of skin penetration. J Invest Dermatol. 1967;48:79–88.CrossRef
9.
go back to reference der Justiz B. Gesetz über den verkehr mit arzneimitteln (arzneimittelgesetz—AMG). BGBl. 2005;I:4530. der Justiz B. Gesetz über den verkehr mit arzneimitteln (arzneimittelgesetz—AMG). BGBl. 2005;I:4530.
10.
go back to reference Herman A, Herman AP. Essential oils and their constituents as skin penetration enhancers for transdermal drug delivery: a review. J Pharm Pharmacol. 2015;67:473–85.CrossRef Herman A, Herman AP. Essential oils and their constituents as skin penetration enhancers for transdermal drug delivery: a review. J Pharm Pharmacol. 2015;67:473–85.CrossRef
11.
go back to reference Chattaraj SC, Walker RB. Penetration enhancer classification. In: Smith EW, Maibach HI, editors. Percutaneous penetration enhancers. CRC Press; 1995. p. 5–20. Chattaraj SC, Walker RB. Penetration enhancer classification. In: Smith EW, Maibach HI, editors. Percutaneous penetration enhancers. CRC Press; 1995. p. 5–20.
12.
go back to reference Yang M, Gong W, Wang Y, Shan L, Li Y, Gao C. Bioavailability improvement strategies for poorly water-soluble drugs based on the supersaturation mechanism: an update. J Pharm Sci. 2016;19:208–25. Yang M, Gong W, Wang Y, Shan L, Li Y, Gao C. Bioavailability improvement strategies for poorly water-soluble drugs based on the supersaturation mechanism: an update. J Pharm Sci. 2016;19:208–25.
13.
go back to reference Edueng K, Mahlin D, Grasjo J, Nylander O, Thakrani M, Bergstrom CAS. Supersaturation potential of amorphous active pharmaceutical ingredients after long-term storage. Molecules. 2019;24:2731.CrossRef Edueng K, Mahlin D, Grasjo J, Nylander O, Thakrani M, Bergstrom CAS. Supersaturation potential of amorphous active pharmaceutical ingredients after long-term storage. Molecules. 2019;24:2731.CrossRef
14.
go back to reference Coe FL, Clark C, Parks JH, Asplin JR. Solid phase assay of urinary cystine supersaturation in the presence of cystine binding drugs. J Urol. 2001;166:688–93.CrossRef Coe FL, Clark C, Parks JH, Asplin JR. Solid phase assay of urinary cystine supersaturation in the presence of cystine binding drugs. J Urol. 2001;166:688–93.CrossRef
15.
go back to reference Sarode AL, Wang P, Obara S, Worthen DR. Supersaturation, nucleation, and crystal growth during single- and biphasic dissolution of amorphous solid dispersions: polymer effects and implications for oral bioavailability enhancement of poorly water soluble drugs. Eur J Pharm Biopharm. 2014;86:351–60.CrossRef Sarode AL, Wang P, Obara S, Worthen DR. Supersaturation, nucleation, and crystal growth during single- and biphasic dissolution of amorphous solid dispersions: polymer effects and implications for oral bioavailability enhancement of poorly water soluble drugs. Eur J Pharm Biopharm. 2014;86:351–60.CrossRef
16.
go back to reference Cilurzo F, Casiraghi A, Selmin F, Minghetti P. Supersaturation as a tool for skin penetration enhancement. Curr Pharm Des. 2015;21:2733–44.CrossRef Cilurzo F, Casiraghi A, Selmin F, Minghetti P. Supersaturation as a tool for skin penetration enhancement. Curr Pharm Des. 2015;21:2733–44.CrossRef
17.
go back to reference Moser K, Kriwet K, Froehlich C, Kalia YN, Guy RH. Supersaturation: enhancement of skin penetration and permeation of a lipophilic drug. Pharm Res. 2001;18:1006–11.CrossRef Moser K, Kriwet K, Froehlich C, Kalia YN, Guy RH. Supersaturation: enhancement of skin penetration and permeation of a lipophilic drug. Pharm Res. 2001;18:1006–11.CrossRef
18.
go back to reference Lebwohl M, Tyring S, Bukhalo M, Alonso-Llamazares J, Olesen M, Lowson D, Yamauchi P. Fixed combination aerosol foam calcipotriene 0.005% (Cal) plus betamethasone dipropionate 0.064% (BD) is more efficacious than Cal or BD aerosol foam alone for psoriasis vulgaris: a randomized, double-blind, multicenter, three-arm, phase 2 study. J Clin Aesthet Dermatol. 2016;9:34–41. Lebwohl M, Tyring S, Bukhalo M, Alonso-Llamazares J, Olesen M, Lowson D, Yamauchi P. Fixed combination aerosol foam calcipotriene 0.005% (Cal) plus betamethasone dipropionate 0.064% (BD) is more efficacious than Cal or BD aerosol foam alone for psoriasis vulgaris: a randomized, double-blind, multicenter, three-arm, phase 2 study. J Clin Aesthet Dermatol. 2016;9:34–41.
19.
go back to reference Koo J, Tyring S, Werschler WP, Bruce S, Olesen M, Villumsen J, Bagel J. Superior efficacy of calcipotriene and betamethasone dipropionate aerosol foam versus ointment in patients with psoriasis vulgaris—a randomized phase II study. J Dermatolog Treat. 2016;27:120–7.CrossRef Koo J, Tyring S, Werschler WP, Bruce S, Olesen M, Villumsen J, Bagel J. Superior efficacy of calcipotriene and betamethasone dipropionate aerosol foam versus ointment in patients with psoriasis vulgaris—a randomized phase II study. J Dermatolog Treat. 2016;27:120–7.CrossRef
20.
go back to reference Paul C, Stein- Gold L, Cambazard F, Kalb RE, Lowson D, Bang B, Griffiths CEM. Cacipotriol plus betamethasone dipropionate aerosol foam provides superior efficacy vs gel in patients with psoriasis vulgaris: randomized, controlled PSO-ABLE study. J Eur Acad Dermatol Venereol. 2017;31:119–26.CrossRef Paul C, Stein- Gold L, Cambazard F, Kalb RE, Lowson D, Bang B, Griffiths CEM. Cacipotriol plus betamethasone dipropionate aerosol foam provides superior efficacy vs gel in patients with psoriasis vulgaris: randomized, controlled PSO-ABLE study. J Eur Acad Dermatol Venereol. 2017;31:119–26.CrossRef
21.
go back to reference Griffiths CE, Stein Gold L, Cambazard F, Kalb RE, Lowson D, Moller A, Paul C. Greater improvement in quality of life outcomes in patients using fixed-combination calcipotriol plus betamethasone dipropionate aerosol foam versus gel: results from the PSO-ABLE study. Eur J Dermatol. 2018;28:356–63.CrossRef Griffiths CE, Stein Gold L, Cambazard F, Kalb RE, Lowson D, Moller A, Paul C. Greater improvement in quality of life outcomes in patients using fixed-combination calcipotriol plus betamethasone dipropionate aerosol foam versus gel: results from the PSO-ABLE study. Eur J Dermatol. 2018;28:356–63.CrossRef
22.
go back to reference Mattozzi C, Salvi M, D’Epiro S, Giancristoforo S, Macaluso L, Luci C, Lal K, Calvieri S, Richetta AG. Importance of regulatory T cells in the pathogenesis of psoriasis: review of the literature. Dermatology. 2013;227:134–45.CrossRef Mattozzi C, Salvi M, D’Epiro S, Giancristoforo S, Macaluso L, Luci C, Lal K, Calvieri S, Richetta AG. Importance of regulatory T cells in the pathogenesis of psoriasis: review of the literature. Dermatology. 2013;227:134–45.CrossRef
23.
go back to reference Jannin V. Complex interplay between solubilization, digestion, supersaturation and absorption of poorly soluble drugs with lipid-based formulations. Curr Drug Deliv. 2018;15:749–51.CrossRef Jannin V. Complex interplay between solubilization, digestion, supersaturation and absorption of poorly soluble drugs with lipid-based formulations. Curr Drug Deliv. 2018;15:749–51.CrossRef
24.
go back to reference Raina SA, Zhang GG, Alonzo DE, Wu J, Zhu D, Catron ND, Gao Y, Taylor LS. Impact of solubilizing additives on supersaturation and membrane transport of drugs. Pharm Res. 2015;32:3350–64.CrossRef Raina SA, Zhang GG, Alonzo DE, Wu J, Zhu D, Catron ND, Gao Y, Taylor LS. Impact of solubilizing additives on supersaturation and membrane transport of drugs. Pharm Res. 2015;32:3350–64.CrossRef
25.
go back to reference Hirakawa Y, Ueda H, Takata Y, Minamihata K, Wakabayashi R, Kamiya N, Goto M. Co-amorphous formation of piroxicam-citric acid to generate supersaturation and improve skin permeation. Eur J Pharm Sci. 2021;158: 105667.CrossRef Hirakawa Y, Ueda H, Takata Y, Minamihata K, Wakabayashi R, Kamiya N, Goto M. Co-amorphous formation of piroxicam-citric acid to generate supersaturation and improve skin permeation. Eur J Pharm Sci. 2021;158: 105667.CrossRef
26.
go back to reference Inoue K, Ogawa K, Okada J, Sugibayashi K. Enhancement of skin permeation of ketotifen by supersaturation generated by amorphous form of the drug. J Control Release. 2005;108:306–18.CrossRef Inoue K, Ogawa K, Okada J, Sugibayashi K. Enhancement of skin permeation of ketotifen by supersaturation generated by amorphous form of the drug. J Control Release. 2005;108:306–18.CrossRef
Metadata
Title
Supersaturation as a Galenic Concept for Improving the Cutaneous Bioavailability of Drugs in Topical Therapy
Authors
Johannes Wohlrab
Adina Eichner
Publication date
21-12-2022
Publisher
Springer Healthcare
Published in
Dermatology and Therapy / Issue 2/2023
Print ISSN: 2193-8210
Electronic ISSN: 2190-9172
DOI
https://doi.org/10.1007/s13555-022-00873-0

Other articles of this Issue 2/2023

Dermatology and Therapy 2/2023 Go to the issue